A diagnostic test that detects Mycoplasma genitalium and identifies genetic markers for antibiotic resistance. The assay combines pathogen detection with resistance profiling to enable resistance-guided therapy.
Manufactured by
SpeeDx Pty Ltd
United States
SpeeDx develops innovative multiplex real-time polymerase chain reaction (qPCR) solutions and specializes in detection of infectious disease pathogens and antimicrobial resistance markers. The SpeeDx product portfolio spans sexually transmitted infections (STIs), respiratory conditions and more. With streamlined product development and manufacturing, SpeeDx is equipped to rapidly respond to customer needs.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Applied Biocode, Inc.
United States · 2 relevant products
APPOLON BIOTECK SAS
France · 3 relevant products
Advanced Molecular Diagnostics Ltd.
United Kingdom · 2 relevant products
56 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 32 relevant matches
Applied Biocode, Inc. · United States
A research use only multiplexed DNA amplification test that enables simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis in one test, plus mutations associated with macrolide and fluoroquinolone resistance. Intended for use with the BioCode® MDx-3000 Instrument.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic panel for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis, with identification of macrolide and fluoroquinolone resistance mutations.
Jiangsu Mole BioScience Co.,Ltd · China
In vitro diagnostic kit for detecting drug resistance genes in Mycoplasma pneumoniae using molecular methods. Enables rapid identification of macrolide and fluoroquinolone resistance markers to guide targeted antimicrobial therapy. Supports clinical decision-making for respiratory tract infections caused by M. pneumoniae.
29 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products